Can Microinfusion of Methotrexate in Scalp Lesions Help Relieve Frontal Fibrosing Alopecia?

    June 2024 in “ BioSCIENCE
    Tatiane Elen E Souza, Thelma Larocca Skare, Nicolau Gregori Czeczko, Orlando Jorge Martins Torres, José Eduardo Ferreira Manso
    Image
    Studysummary This study reviewed the use of microinfusion of microparticles (MMP®) with methotrexate for treating alopecia frontal fibrosante and found it reduced symptoms associated with the condition and improved specific scalp measurements, showing that the technique is safe and well-tolerated.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study reviews the efficacy of using microinfusion of methotrexate (MTX) for treating frontal fibrosing alopecia, a type of scarring alopecia. This minimally invasive technique, known as MMP®, was found to significantly reduce symptoms and improve hairline measurements in affected areas. The procedure was deemed safe and well-tolerated, suggesting it could be a beneficial treatment option for this condition.
    Discuss this study in the Community →